TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.

Ben Y Durkee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.